Form 8-K - Current report:
SEC Accession No. 0001193125-24-231167
Filing Date
2024-10-02
Accepted
2024-10-02 16:15:00
Documents
15
Period of Report
2024-10-02
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d888487d8k.htm   iXBRL 8-K 29047
2 EX-3.1 d888487dex31.htm EX-3.1 5126
3 EX-3.2 d888487dex32.htm EX-3.2 118771
  Complete submission text file 0001193125-24-231167.txt   317786

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA clym-20241002.xsd EX-101.SCH 2497
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20241002_lab.xml EX-101.LAB 19601
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20241002_pre.xml EX-101.PRE 12178
17 EXTRACTED XBRL INSTANCE DOCUMENT d888487d8k_htm.xml XML 4130
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 241347502
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)